Spots Global Cancer Trial Database for apatinib 500mg
Every month we try and update this database with for apatinib 500mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC | NCT03201146 | Lung Cancer Non Small Cell ... Combination Che... Apatinib | Apatinib AP or AC Apatinib 250mg Apatinib 500mg Apatinib 750mg | 18 Years - 70 Years | West China Hospital | |
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer | NCT04208347 | Gastric and Gas... | Apatinib 250mg Camrelizumab S-1, Oxaliplati... Apatinib 500mg | 18 Years - 75 Years | Ruijin Hospital |